Daclatasvir
Drug timelines are a Plus or Pro feature.
51 regulatory and trial events tracked for Daclatasvir, covering 2013-11-22 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO) [Phase 2]